Impact of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Randomised Multicentre Study.

Glucose control Health-related objects Lifestyle management Tele-education Telemonitoring Type 2 diabetes

Journal

Diabetes therapy : research, treatment and education of diabetes and related disorders
ISSN: 1869-6953
Titre abrégé: Diabetes Ther
Pays: United States
ID NLM: 101539025

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 31 03 2021
accepted: 05 06 2021
pubmed: 24 6 2021
medline: 24 6 2021
entrez: 23 6 2021
Statut: ppublish

Résumé

Telemonitoring in type 2 diabetes (T2D) is mainly based on glucose monitoring. A new type of connected device which routinely gathers data on weight, physical activity and food intake could improve patients' diabetes control. The main aim of this study was to assess the efficacy of an at-home interventional programme incorporating such devices and lifestyle education software on diabetes control, i.e., change in HbA1c, compared to standard care. This multicentre study randomly assigned 282 people with T2D to either a telemonitoring group (TMG) or a control group (CG) for a 1-year intervention period. While routine follow-up was maintained in the CG, TMG subjects were provided with interactive lifestyle educational software (with artificial intelligence algorithms) and connected objects (blood glucose meters, scales and actimeters) for use in their own homes and were remotely monitored by their diabetologists. Changes in HbA The mean HbA The EDUC@DOM telemonitoring and tele-education device did not highlight a significant decrease in HbA1c levels compared to routine management although a slight, albeit significant improvement in glycaemic control was observed in the frequent user subgroup as well as significant weight loss but only in women. A high level of satisfaction with the connected device was recorded amongst all participants. This trial was registered in the Clinical Trials Database on September 27, 2013, under no. NCT01955031 and bears ID-RCB number 2013-A00391-44.

Identifiants

pubmed: 34160791
doi: 10.1007/s13300-021-01095-x
pii: 10.1007/s13300-021-01095-x
pmc: PMC8266949
doi:

Banques de données

ClinicalTrials.gov
['NCT01955031']

Types de publication

Journal Article

Langues

eng

Pagination

2059-2075

Subventions

Organisme : Ministère des Affaires Sociales, de la Santé et des Droits des Femmes
ID : 12-018-0078
Organisme : Conseil Régional Midi-Pyrénées
ID : 11052617
Organisme : Conseil Régional Midi-Pyrénées
ID : 13050630

Références

Diabetes Care. 2018 Dec;41(12):2669-2701
pubmed: 30291106
J Telemed Telecare. 2012 Jun;18(4):211-20
pubmed: 22674020
Diabetes Care. 1992 Feb;15(2):204-12
pubmed: 1547677
Diabetes Care. 2020 Feb;43(2):337-342
pubmed: 31831473
Br J Nurs. 2018 Oct 18;27(19):1115-1120
pubmed: 30346819
Int J Epidemiol. 2014 Aug;43(4):1272-83
pubmed: 24881045
Int J Behav Nutr Phys Act. 2016 Dec 7;13(1):127
pubmed: 27927218
Diabetes Care. 2002 Nov;25(11):1952-7
pubmed: 12401738
Diabetol Metab Syndr. 2017 Jul 11;9:52
pubmed: 28702091
Telemed J E Health. 2018 Aug;24(8):604-613
pubmed: 29341843
Sci Rep. 2017 Oct 4;7(1):12680
pubmed: 28978949
Diabetes Care. 2011 Mar;34(3):533-9
pubmed: 21266648
Diabetes Technol Ther. 2019 Sep;21(9):514-521
pubmed: 31287736
Diabetes Metab. 2001 Apr;27(2 Pt 1):139-47
pubmed: 11353880
Telemed J E Health. 2012 Apr;18(3):175-84
pubmed: 22356525
N Engl J Med. 1993 Sep 30;329(14):977-86
pubmed: 8366922
Diabetes Care. 2011 Sep;34(9):1934-42
pubmed: 21788632
Diabetes Care. 2010 Apr;33(4):745-7
pubmed: 20103547
J Telemed Telecare. 2016 Sep;22(6):363-8
pubmed: 26468213
Artif Intell Med. 2008 Mar;42(3):213-27
pubmed: 18261889
Diabetes Technol Ther. 2010 Mar;12(3):213-20
pubmed: 20151772
J Med Internet Res. 2015 Jul 21;17(7):e181
pubmed: 26199208
J Diabetes Res. 2018 May 16;2018:3961730
pubmed: 29888288
Lancet. 1998 Sep 12;352(9131):837-53
pubmed: 9742976
Diabetes Res Clin Pract. 2017 Sep;131:70-81
pubmed: 28692830
Diabete Metab. 1995 Feb;21(1):26-33
pubmed: 7781839
J Med Internet Res. 2015 Oct 23;17(10):e240
pubmed: 26499966
Am J Med Sci. 2017 Jan;353(1):1-5
pubmed: 28104096
Diabetes Care. 2006 Dec;29(12):2625-31
pubmed: 17130195
J Telemed Telecare. 2012 Apr;18(3):164-8
pubmed: 22362832
BMC Fam Pract. 2008 Apr 11;9:20
pubmed: 18405345
BMC Health Serv Res. 2018 Jun 26;18(1):495
pubmed: 29940936
JMIR Mhealth Uhealth. 2014 Dec 11;2(4):e57
pubmed: 25499872
Stat Med. 1992 Sep 30;11(13):1685-704
pubmed: 1485053
Diabetes Care. 2012 Jan;35 Suppl 1:S11-63
pubmed: 22187469
J Telemed Telecare. 2012 Dec;18(8):447-50
pubmed: 23209266
PLoS One. 2013 Nov 08;8(11):e79246
pubmed: 24250826

Auteurs

Marie-Christine Turnin (MC)

Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, 1 Avenue Jean Poulhès, TSA 50032, Toulouse cedex 9, 31059, Toulouse, France. turnin.mc@chu-toulouse.fr.

Pierre Gourdy (P)

Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, 1 Avenue Jean Poulhès, TSA 50032, Toulouse cedex 9, 31059, Toulouse, France.
Institute of Metabolic and Cardiovascular Diseases, UMR1297 INSERM/UPS, Toulouse University, Toulouse, France.

Jacques Martini (J)

Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, 1 Avenue Jean Poulhès, TSA 50032, Toulouse cedex 9, 31059, Toulouse, France.
DIAMIP Network, Toulouse, France.

Jean-Christophe Buisson (JC)

ENSEEIHT, Toulouse, France.

Marie-Christine Chauchard (MC)

Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, 1 Avenue Jean Poulhès, TSA 50032, Toulouse cedex 9, 31059, Toulouse, France.
DIAMIP Network, Toulouse, France.

Jacqueline Delaunay (J)

Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, 1 Avenue Jean Poulhès, TSA 50032, Toulouse cedex 9, 31059, Toulouse, France.

Solène Schirr-Bonnans (S)

Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, 1 Avenue Jean Poulhès, TSA 50032, Toulouse cedex 9, 31059, Toulouse, France.

Soumia Taoui (S)

Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, 1 Avenue Jean Poulhès, TSA 50032, Toulouse cedex 9, 31059, Toulouse, France.

Marie-France Poncet (MF)

Claude Bernard Clinic, Albi, France.

Valeria Cosma (V)

Nîmes Hospital Centre, Nimes, France.

Sandrine Lablanche (S)

University Hospital, Grenoble, France.

Magali Coustols-Valat (M)

Ambroise Paré Clinic, Toulouse, France.

Lucie Chaillous (L)

University Hospital, Nantes, France.

Charles Thivolet (C)

University Hospital, Lyon, France.

Caroline Sanz (C)

Pasteur Clinic, Toulouse, France.

Alfred Penfornis (A)

Sud Francilien Hospital, Corbeil-Essonnes and Paris-Saclay University, Paris, France.

Benoît Lepage (B)

University Department of Epidemiology, Health Economics and Public Health, University Hospital, Toulouse, France.

Hélène Colineaux (H)

University Department of Epidemiology, Health Economics and Public Health, University Hospital, Toulouse, France.

Michaël Mounié (M)

Medico-Economic Unit, Medical Information Department, University Hospital, Toulouse, France.

Nadège Costa (N)

Medico-Economic Unit, Medical Information Department, University Hospital, Toulouse, France.

Laurent Molinier (L)

Medico-Economic Unit, Medical Information Department, University Hospital, Toulouse, France.

Hélène Hanaire (H)

Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, 1 Avenue Jean Poulhès, TSA 50032, Toulouse cedex 9, 31059, Toulouse, France.
Institute of Metabolic and Cardiovascular Diseases, UMR1297 INSERM/UPS, Toulouse University, Toulouse, France.

Classifications MeSH